The failure of torcetrapib: is there a case for independent preclinical and clinical testing?--correspondence

Expert Opin Pharmacother. 2008 Oct;9(14):2561-2; author reply 2563-4. doi: 10.1517/14656566.9.14.2561.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Quinolines / therapeutic use*
  • Research Design
  • Treatment Outcome

Substances

  • Anticholesteremic Agents
  • Quinolines
  • torcetrapib